Evidence map›Paper›PMID 31702020›Full record

ArticleMolecular medicine reports2019

Anti‑gouty arthritis and anti‑hyperuricemia properties of celery seed extracts in rodent models.

Shaopeng Li, Lanzhou Li, Han Yan, Xue Jiang, Weiwei Hu, Ning Han, Di Wang

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06084585 (A Three Arms, Randomized, Double-blind Controlled Trial of the Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia), which is not on this map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06084585 naunknown statusnot on this mapstarted 2023, after this paper: background citation

A Three Arms, Randomized, Double-blind Controlled Trial of the Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia

TypeinterventionalSponsorAmway (China) R&D CenterRan2023 to 2024Enrolled180ConditionsHyperuricemiaArmsStudy Product A (High-dose 2X), Study Product B (Low-dose X), Placebo
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. High Flavonoid Content inPharmaceutical nanotechnology · 2026
    Article
  6. Article
  7. Hyperuricemia predicts adverse clinical outcomes after arthroscopic microfracture of osteochondral lesions of the talus.Asia-Pacific journal of sports medicine, arthroscopy, rehabilitation and technology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Postbiotic ofFoods (Basel, Switzerland) · 2024
    Article
  13. Ethanol Extracts fromFoods (Basel, Switzerland) · 2024
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Fatty Acid-Rich Extract fromMolecules (Basel, Switzerland) · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shaopeng LiSchool of Life Sciences, Jilin University, Changchun, Jilin 130012, P.R. China.
Lanzhou LiSchool of Life Sciences, Jilin University, Changchun, Jilin 130012, P.R. China.
Han YanSchool of Life Sciences, Jilin University, Changchun, Jilin 130012, P.R. China.
Xue JiangSchool of Life Sciences, Jilin University, Changchun, Jilin 130012, P.R. China.
Weiwei HuSchool of Life Sciences, Jilin University, Changchun, Jilin 130012, P.R. China.
Ning HanDepartment of Ophthalmology, The Second Hospital of Jilin University, Jilin University, Changchun, Jilin 130041, P.R. China.
Di WangSchool of Life Sciences, Jilin University, Changchun, Jilin 130012, P.R. China.
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gout is a type of serious arthritis that is caused by hyperuricemia. Celery is an umbelliferous plant that was shown to exhibit anti‑inflammatory activity in rodent. The present study aimed to investigate the effects and potential preliminary mechanisms of celery seed aqueous extract (CSAE) and celery seed oil extract (CSOL) for gout treatment. The components of CSAE and CSOL were systematically analyzed. In mice with hyperuricemia induced by potassium oxonate and yeast extract, CSAE and CSOL treatment reduced the serum levels of uric acid and xanthine oxidase. In addition, CSAE and CSOL reduced the levels of reactive oxygen species and increased the serum levels of superoxide dismutase and glutathione peroxidase in mouse serum. In rats with acute gouty arthritis induced by intra‑articular injection of monosodium urate crystals, CSAE and CSOL treatment alleviated the swelling of the ankle joints and reduced inflammatory cell infiltration around the ankle joints. In addition, CSAE and CSOL reduced the levels of interleukin (IL)‑1β and tumor necrosis factor α and increased the levels of IL‑10. The results of the present study suggested that celery seed extracts may have anti‑gout properties, partially through anti‑inflammatory and antioxidative effects.

Indexed as

AnimalsApiumArthritis, GoutyHyperuricemiaInterleukin-10Interleukin-1betaMaleMiceMice, Inbred BALB CPlant ExtractsSeedsIL10 protein, mouseIL1B protein, mouseInterleukin-10Interleukin-1betaPlant Extracts

Identifiers

PMID31702020
PMCPMC6797962
OpenAlexW2975296005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.